Whittier Trust Co. Has $19.14 Million Stock Holdings in SPDR S&P Biotech ETF $XBI

Whittier Trust Co. trimmed its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 29.5% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 230,769 shares of the exchange traded fund’s stock after selling 96,332 shares during the quarter. Whittier Trust Co. owned 0.43% of SPDR S&P Biotech ETF worth $19,137,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Activest Wealth Management lifted its position in shares of SPDR S&P Biotech ETF by 647.0% during the 2nd quarter. Activest Wealth Management now owns 874 shares of the exchange traded fund’s stock valued at $72,000 after acquiring an additional 757 shares during the period. 5th Street Advisors LLC lifted its position in shares of SPDR S&P Biotech ETF by 5.1% during the 2nd quarter. 5th Street Advisors LLC now owns 18,072 shares of the exchange traded fund’s stock valued at $1,499,000 after acquiring an additional 882 shares during the period. RFG Advisory LLC bought a new stake in shares of SPDR S&P Biotech ETF during the 2nd quarter valued at $208,000. Fulcrum Capital LLC lifted its position in shares of SPDR S&P Biotech ETF by 6.0% during the 2nd quarter. Fulcrum Capital LLC now owns 54,960 shares of the exchange traded fund’s stock valued at $4,558,000 after acquiring an additional 3,122 shares during the period. Finally, Robertson Stephens Wealth Management LLC lifted its position in shares of SPDR S&P Biotech ETF by 36.4% during the 2nd quarter. Robertson Stephens Wealth Management LLC now owns 4,721 shares of the exchange traded fund’s stock valued at $392,000 after acquiring an additional 1,261 shares during the period.

SPDR S&P Biotech ETF Stock Performance

NYSEARCA:XBI opened at $110.17 on Tuesday. The stock has a fifty day moving average price of $96.56 and a 200-day moving average price of $86.95. The company has a market cap of $6.84 billion, a price-to-earnings ratio of 11.47 and a beta of 0.97. SPDR S&P Biotech ETF has a fifty-two week low of $66.66 and a fifty-two week high of $110.96.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.